Antibodies binding to citrullinated proteins (ACPA) are a rheumatoid arthritis-specific finding that can precede clinical disease onset by several years [1], which suggests that these antibodies and their antigens could play a role in the disease pathogenesis. The gene discussed is PRTN3; the disease is rheumatoid arthritis.